// App-Quantinova.ai

1837 : Transcriptional Heterogeneity Governs Cell Fate Diversification during Pre-Leukemia to Leukemia Progression

Researchers

Presenter

  • Shikha Gupta

Principal Investigators

  • Ana Filipa Domingues

  • Oliwia Cyran

  • George Giotopoulos

  • Sudhakaran Prabakaran

  • Brian J. P. Huntly

  • Oliver M. Dovey

  • George S. Vassiliou

  • Cristina Pina

Medical Centers

  • Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  • Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  • Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom

  • Wellcome Trust Sanger Institute, Cambridge, United Kingdom

  • Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  • Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, United Kingdom

  • Indian Institute of Science Education and Research,

  • Department of Haematology, Hills Road, Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom

  • Wellcome Trust Sanger Institute, Cambridge, United Kingdom

  • College of Health, Medicine and Life Sciences - Division of Biosciences, Brunel University London, London, United Kingdom

Locations

  • United Kingdom

  • India

Companies

  • Wellcome Sanger Inst

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • p70S6 kinase

  • Protein AF-9

  • Histone-lysine N-methyltransferase 2A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved